USANA Health Sciences (NYSE:USNA) Cut to “Hold” at Sidoti

Sidoti lowered shares of USANA Health Sciences (NYSE:USNA) from a strong-buy rating to a hold rating in a research report report published on Tuesday morning,Zacks.com reports.

Several other research firms have also recently weighed in on USNA. DA Davidson lifted their target price on USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a research note on Thursday, January 2nd. StockNews.com cut USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th.

USANA Health Sciences Price Performance

NYSE:USNA opened at $32.17 on Tuesday. USANA Health Sciences has a fifty-two week low of $30.13 and a fifty-two week high of $50.32. The stock’s 50-day moving average is $33.91 and its two-hundred day moving average is $36.82. The stock has a market cap of $613.08 million, a PE ratio of 11.37, a price-to-earnings-growth ratio of 0.85 and a beta of 0.87.

Institutional Investors Weigh In On USANA Health Sciences

Several large investors have recently made changes to their positions in USNA. Pacer Advisors Inc. grew its stake in shares of USANA Health Sciences by 16.5% in the 3rd quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock valued at $20,638,000 after buying an additional 76,904 shares in the last quarter. Pzena Investment Management LLC grew its stake in shares of USANA Health Sciences by 7.5% in the 3rd quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock valued at $39,801,000 after buying an additional 72,977 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of USANA Health Sciences by 7.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock valued at $27,751,000 after buying an additional 55,059 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of USANA Health Sciences by 14,068.2% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock valued at $1,472,000 after buying an additional 38,547 shares in the last quarter. Finally, Jane Street Group LLC grew its stake in shares of USANA Health Sciences by 330.0% in the 4th quarter. Jane Street Group LLC now owns 39,979 shares of the company’s stock valued at $1,435,000 after buying an additional 30,681 shares in the last quarter. Institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.